ArticleAmerican journal of cancer research2019

MiR-374b re-sensitizes hepatocellular carcinoma cells to sorafenib therapy by antagonizing PKM2-mediated glycolysis pathway.

Mukun Zhang et al.PubMed ↗Full text ↗

No numbers read from the abstract.